Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)

SHE:000952 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	422.36	307.18	415.24	431.35	293.33	350.31
Cash & Short-Term Investments	422.36	307.18	415.24	431.35	293.33	350.31
Cash Growth	4.61%	-26.02%	-3.74%	47.05%	-16.26%	77.44%
Accounts Receivable	192.65	223.19	297.42	294.62	197.61	147.31
Other Receivables	17.77	6.64	6.08	-	0.55	0.26
Receivables	210.41	229.83	303.51	299.7	203.33	161.03
Inventory	353.53	322.03	298.99	221.47	164.83	163.57
Other Current Assets	68.37	61.78	66.93	52.97	47.47	27.17
Total Current Assets	1,055	920.82	1,085	1,005	708.96	702.08
Property, Plant & Equipment	1,553	1,577	1,637	1,199	1,069	1,042
Long-Term Investments	7.28	7.28	35.2	44.13	39.79	22.64
Other Intangible Assets	238.03	239.62	216.91	150.62	154.72	161.57
Long-Term Deferred Tax Assets	20.74	20.73	15.88	27.73	24.81	21.76
Long-Term Deferred Charges	8.47	9.12	10.15	0.58	-	0.12
Other Long-Term Assets	11.55	18.82	30.13	42.25	51.43	29.36
Total Assets	2,893	2,794	3,030	2,470	2,049	1,979
Accounts Payable	132.05	121.22	143.02	178.6	121.62	139.1
Accrued Expenses	21.95	33.67	33.54	32.24	36.94	42.52
Short-Term Debt	488.74	344.24	291.06	197.13	241.71	207.22
Current Portion of Long-Term Debt	-	132.8	161.5	158.91	99.61	15.81
Current Portion of Leases	-	1.05	1.59	1.2	0.84	-
Current Income Taxes Payable	8.81	0.37	0.22	1.85	2.61	7.59
Current Unearned Revenue	9.43	6.4	7.07	5.49	12.13	19.87
Other Current Liabilities	472.14	287.77	227.87	78.61	24.82	28.33
Total Current Liabilities	1,133	927.51	865.87	654.03	540.29	460.43
Long-Term Debt	709.41	393.75	417.29	301.56	34.45	124.43
Long-Term Leases	1.35	1.35	2.25	3.19	1.65	-
Long-Term Unearned Revenue	12.71	13.3	15.65	18.12	21.04	23.29
Long-Term Deferred Tax Liabilities	0.5	0.5	0.69	0.92	0.33	-
Other Long-Term Liabilities	-	380.96	335.32	0.34	0.33	5.6
Total Liabilities	1,857	1,717	1,637	978.17	598.09	613.75
Common Stock	349.86	349.86	353.86	353.97	344	347
Additional Paid-In Capital	377.12	377.12	391.79	391.09	353.92	380.94
Retained Earnings	322	358.27	653.56	793.8	764.58	675.12
Treasury Stock	-21.23	-21.23	-35.75	-36.19	-	-30
Comprehensive Income & Other	1.14	0.93	-0.01	-0.02	-0.03	0.02
Total Common Equity	1,029	1,065	1,363	1,503	1,462	1,373
Minority Interest	7.37	11.26	29	-10.83	-11.67	-7.39
Shareholders' Equity	1,036	1,076	1,392	1,492	1,451	1,366
Total Liabilities & Equity	2,893	2,794	3,030	2,470	2,049	1,979
Total Debt	1,200	873.19	873.69	662	378.26	347.46
Net Cash (Debt)	-777.14	-566.01	-458.45	-230.65	-84.93	2.84
Net Cash Per Share	-2.22	-1.61	-1.30	-0.65	-0.25	0.01
Filing Date Shares Outstanding	349.86	349.86	353.86	353.97	344	344
Total Common Shares Outstanding	349.86	349.86	353.86	353.97	344	344
Working Capital	-78.45	-6.69	218.8	351.46	168.67	241.65
Book Value Per Share	2.94	3.04	3.85	4.25	4.25	3.99
Tangible Book Value	790.85	825.32	1,147	1,352	1,308	1,212
Tangible Book Value Per Share	2.26	2.36	3.24	3.82	3.80	3.52
Buildings	-	1,163	1,196	899.49	839.29	795.03
Machinery	-	1,456	1,370	942.21	840.98	816.55
Construction In Progress	-	33.1	60.96	258.14	204.47	166.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.